60 related articles for article (PubMed ID: 16973883)
21. Mechanistic determinants of biotherapeutics absorption following SC administration.
Richter WF; Bhansali SG; Morris ME
AAPS J; 2012 Sep; 14(3):559-70. PubMed ID: 22619041
[TBL] [Abstract][Full Text] [Related]
22. Erythropoietin-coated ZP-microneedle transdermal system: preclinical formulation, stability, and delivery.
Peters EE; Ameri M; Wang X; Maa YF; Daddona PE
Pharm Res; 2012 Jun; 29(6):1618-26. PubMed ID: 22258935
[TBL] [Abstract][Full Text] [Related]
23. Lifespan based indirect response models.
Krzyzanski W; Perez Ruixo JJ
J Pharmacokinet Pharmacodyn; 2012 Feb; 39(1):109-23. PubMed ID: 22212685
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic/pharmacodynamic modeling of GLP-1 in healthy rats.
Cao Y; Gao W; Jusko WJ
Pharm Res; 2012 Apr; 29(4):1078-86. PubMed ID: 22179928
[TBL] [Abstract][Full Text] [Related]
25. Mechanism-based disease progression modeling of type 2 diabetes in Goto-Kakizaki rats.
Gao W; Bihorel S; DuBois DC; Almon RR; Jusko WJ
J Pharmacokinet Pharmacodyn; 2011 Feb; 38(1):143-62. PubMed ID: 21127951
[TBL] [Abstract][Full Text] [Related]
26. Simultaneous pharmacokinetics/pharmacodynamics modeling of recombinant human erythropoietin upon multiple intravenous dosing in rats.
Ait-Oudhia S; Scherrmann JM; Krzyzanski W
J Pharmacol Exp Ther; 2010 Sep; 334(3):897-910. PubMed ID: 20501635
[TBL] [Abstract][Full Text] [Related]
27. Quantitative analysis of mechanisms that govern red blood cell age structure and dynamics during anaemia.
Savill NJ; Chadwick W; Reece SE
PLoS Comput Biol; 2009 Jun; 5(6):e1000416. PubMed ID: 19557192
[TBL] [Abstract][Full Text] [Related]
28. Scaling pharmacodynamics from in vitro and preclinical animal studies to humans.
Mager DE; Woo S; Jusko WJ
Drug Metab Pharmacokinet; 2009; 24(1):16-24. PubMed ID: 19252333
[TBL] [Abstract][Full Text] [Related]
29. Basic pharmacodynamic models for agents that alter the lifespan distribution of natural cells.
Krzyzanski W; Perez-Ruixo JJ; Vermeulen A
J Pharmacokinet Pharmacodyn; 2008 Jun; 35(3):349-77. PubMed ID: 18551354
[TBL] [Abstract][Full Text] [Related]
30. Pharmacodynamic analysis of recombinant human erythropoietin effect on reticulocyte production rate and age distribution in healthy subjects.
Pérez-Ruixo JJ; Krzyzanski W; Hing J
Clin Pharmacokinet; 2008; 47(6):399-415. PubMed ID: 18479174
[TBL] [Abstract][Full Text] [Related]
31. Target-mediated pharmacokinetic and pharmacodynamic model of recombinant human erythropoietin (rHuEPO).
Woo S; Krzyzanski W; Jusko WJ
J Pharmacokinet Pharmacodyn; 2007 Dec; 34(6):849-68. PubMed ID: 17943422
[TBL] [Abstract][Full Text] [Related]
32. Pharmacodynamic model for chemotherapy-induced anemia in rats.
Woo S; Krzyzanski W; Jusko WJ
Cancer Chemother Pharmacol; 2008 Jun; 62(1):123-33. PubMed ID: 17891399
[TBL] [Abstract][Full Text] [Related]
33. Spatiotemporal control over growth factor signaling for therapeutic neovascularization.
Cao L; Mooney DJ
Adv Drug Deliv Rev; 2007 Nov; 59(13):1340-50. PubMed ID: 17868951
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after single and multiple doses in healthy volunteers.
Ramakrishnan R; Cheung WK; Wacholtz MC; Minton N; Jusko WJ
J Clin Pharmacol; 2004 Sep; 44(9):991-1002. PubMed ID: 15317827
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after intravenous and subcutaneous dose administration in cynomolgus monkeys.
Ramakrishnan R; Cheung WK; Farrell F; Joffee L; Jusko WJ
J Pharmacol Exp Ther; 2003 Jul; 306(1):324-31. PubMed ID: 12676891
[TBL] [Abstract][Full Text] [Related]
36. Interspecies comparisons of pharmacokinetics and pharmacodynamics of recombinant human erythropoietin.
Woo S; Jusko WJ
Drug Metab Dispos; 2007 Sep; 35(9):1672-8. PubMed ID: 17576810
[TBL] [Abstract][Full Text] [Related]
37. Physiological and pharmacodynamic considerations for route of EPO administration.
Besarab A
Semin Nephrol; 2000 Jul; 20(4):364-74. PubMed ID: 10928339
[TBL] [Abstract][Full Text] [Related]
38. Novel erythropoiesis stimulating protein.
Macdougall IC
Semin Nephrol; 2000 Jul; 20(4):375-81. PubMed ID: 10928340
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after intravenous and subcutaneous administration in rats.
Woo S; Krzyzanski W; Jusko WJ
J Pharmacol Exp Ther; 2006 Dec; 319(3):1297-306. PubMed ID: 16973883
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
